The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cells

Molecular Brain Research

Volumn 106, Issue 1-2, 2002, Pages 42-49

  Waltereit, Robert ^a   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Astrocytoma; Caspase 9; Caspase 9S; Cell death; Malignant transformation

Indexed keywords

CASPASE 9; CASPASE 9S; ENZYME VARIANT; LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASTROCYTOMA; CASPASE 9; CASPASES; FAS LIGAND PROTEIN; HUMANS; ISOENZYMES; LIGANDS; MEMBRANE GLYCOPROTEINS; NEUROBLASTOMA; TENIPOSIDE; TRANSGENES; TUMOR CELLS, CULTURED;

MAMMALIA;

EID: 0037109158     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(02)00408-4     Document Type: Article

References (19)

1. Duan H., Orth K., Chinnaiyan A.M., Poirier G.G., Froelich C.J., He W.W., Dixit V.M. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271:1996;16720-16724.
2. Ferreira C.G., Span S.W., Peters G.J., Kruyt F.A., Giaccone G. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res. 60:2000;7133-7141.
3. Glaser T., Wagenknecht B., Groscurth P., Krammer P.H., Weller M. Death ligand/receptor-independent caspase activation mediates drug-induced cell death in malignant glioma cells. Oncogene. 18:1999;5044-5053.
4. Glaser T., Weller M. Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun. 281:2001;322-327.
5. Glaser T., Wagenknecht B., Weller M. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene. 20:2001;4757-4767.
6. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshida R., Kaufman S.A., Lowe S.W., Penninger J.M., Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell. 94:1998;339-352.
7. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
8. Kuida K., Haydar T.F., Kuan C.Y., Gu Y., Taya C., Karasuyama H., Su M.S., Rakic P., Flavell R.A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 94:1998;325-337.
9. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
10. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
11. Rensing-Ehl A., Frei K., Flury R., Matiba B., Mariani S.M., Weller M., Aebischer P., Krammer P.H., Fontana A. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25:1995;2253-2258.
12. Seol D.W., Billiar T.R. A caspase 9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J. Biol. Chem. 274:1999;2072-2076.
13. Srinivasula S.M., Fernandes-Alnemri T., Zangrilli J., Robertson N., Armstrong R.C., Wang L., Trapani J.A., Tomaselli K.J., Litwack G., Alnemri E.S. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J. Biol. Chem. 271:1996;27099-27106.
14. Srinivasula S.M., Ahmad M., Guo Y., Zhan Y., Lazebnik Y., Fernandes-Alnemri T., Alnemri E.S. Identification of an endogenous dominant-negative short isoform of caspase 9 that can regulate apoptosis. Cancer Res. 59:1999;999-1002.
15. Sun X.M., MacFarlane M., Zhuang J., Wolf B.B., Green D.R., Cohen G.M. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J. Biol. Chem. 274:1999;5053-5060.
16. Wagenknecht B., Glaser T., Naumann U., Kügler S., Isenmann S., Bähr M., Korneluk R., Liston P., Weller M. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ. 6:1999;370-376.
17. Weller M., Frei K., Groscurth P., Krammer P.H., Yonekawa Y., Fontana A. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:1994;954-964.
18. Weller M., Rieger J., Grimmel C., Van Meir E.G., De Tribolet N., Krajewski S., Reed J.C., von Deimling A., Dichgans J. Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int. J. Cancer. 79:1998;640-644.
19. Zheng T.S., Hunot S., Kuida K., Momoi T., Srinivasan A., Nicholson D.W., Lazebnik Y., Flavell R.A. Deficiency in caspase 9 or caspase-3 induces compensatory caspase activation. Nat. Med. 6:2000;1241-1247.